ESR1 and neoplasm: There is one confounding factor that is difficult to overcome when attributing the data to the treatment groups: the treatment given to a patient is dictated by the physical characteristics of the tumor, i.e. the presence of the estrogen receptor, amplification of ERBB2, size of the tumor, in situ versus invasive components and lymph node involvement.